Experts say the UK government may have chosen the least cost-effective vaccine to immunise young teenage girls against viruses that cause cervical cancer.
MORE than 5,000 Sussex schoolgirls aged 12 to 13 are being offered their human papilloma virus (HPV) vaccination to protect them against cervical cancer.